The asthma‐rhinitis multimorbidity is associated with IgE polysensitization in adolescents and adults
Abstract
Background: Children with multimorbid asthma and rhinitis show IgE polysensitization to several allergen sources. This association remains poorly studied in adolescents and adults using defined allergen molecules. We investigated IgE sensitization patterns towards a broad panel of aeroallergen components in adults and adolescents with a focus on individuals with asthma and rhinitis multimorbidity.Methods: IgE reactivity to 64 micro‐arrayed aeroallergen molecules was determined with the MeDALL‐chip in samples from the French EGEA study (n = 840, age = 40.7 ± 17.1) and the Swedish population‐based birth cohort BAMSE (n = 786, age = 16 ± 0.26). The age‐ and sex‐adjusted associations between the number of IgE‐reactive allergen molecules (≥0.3 ISU) and the asthma‐rhinitis phenotypes were assessed using a negative binomial model.Results: Groups representing 4 phenotypes were identified: no asthma‐no rhinitis (A−R−; 30% in EGEA and 54% in BAMSE), asthma alone (A+R−; 11% and 8%), rhinitis alone (A−R+; 15% and 24%) and asthma‐rhinitis (A+R+; 44% and 14%). The numbers of IgE‐reactive aeroallergen molecules significantly differed between phenotypes (median in A−R−, A+R−, A−R+ and A+R+: 0, 1, 2 and 7 in EGEA and 0, 0, 3 and 5 in BAMSE). As compared to A−R− subjects, the adjusted ratio of the mean number of IgE‐reactive molecules was higher in A+R+ than in A+R− or A−R+ (10.0, 5.4 and 5.0 in EGEA and 7.2, 0.7 and 4.8 in BAMSE).Conclusion: The A+R+ phenotype combined the sensitization pattern of both the A−R+ and A+R− phenotypes. This multimorbid polysensitized phenotype seems to be generalizable to various ages and allergenic environments and may be associated with specific mechanisms.Keywords
Funding Information
- Austrian Science Fund
- Seventh Framework Programme (261357)
- Hjärt-Lungfonden
- Vetenskapsrådet
- Stockholms Läns Landsting
This publication has 32 references indexed in Scilit:
- Advances in allergen-microarray technology for diagnosis and monitoring of allergy: The MeDALL allergen-chipMethods, 2014
- Comorbidity of eczema, rhinitis, and asthma in IgE-sensitised and non-IgE-sensitised children in MeDALL: a population-based cohort studyThe Lancet Respiratory Medicine, 2014
- A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnosticsWorld Allergy Organization Journal, 2013
- Cross‐reactions vs co‐sensitization evaluated by in silico motifs and in vitro IgE microarray testingAllergy, 2011
- MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicineAllergy, 2011
- Effect of 17q21 Variants and Smoking Exposure in Early-Onset AsthmaNew England Journal of Medicine, 2008
- Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens. A GA2LEN projectAllergy, 2006
- Isolation of the main allergen Fra e 1 from ash (Fraxinus excelsior) pollen: comparison of the natural and recombinant formsAnnals of Allergy, Asthma & Immunology, 2006
- Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatmentThe FASEB Journal, 2002
- Epidemiological Study of the Genetics and Environment of Asthma, Bronchial Hyperresponsiveness, and AtopyAmerican Journal of Respiratory and Critical Care Medicine, 1997